The impact of Brexit on the pharmaceutical and medical device industries

Our European Life Sciences Regulatory team has been examining the potential consequences of Brexit for the pharmaceutical and medical device industries since before the results of the...

CBD and the changing regulatory landscape for hemp-derived products

Please join us on Tuesday, February 26 for a webinar on the regulatory landscape for hemp-derived products, including cannabidiol, or CBD.

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

Going Global 2018

Cross-practice, multi-track seminar on advanced trademark issues, global M&A transactions, global patent updates for technology companies, energy investments, and recent...

Life Sciences BREXIT Countdown

We have been examining the potential consequences of BREXIT for the pharmaceutical and medical device industries since before the results of the referendum were known. We are working with...

The 6th Annual Value-Based Health Care Congress

Chris Schott served as the moderator for the "Overcome Market Access Challenges and Develop Effective Value-Based Contracts for Cell and Gene Therapies and Orphan Drugs" panel in...

Master Class: Medical Device Clinical Research: The Path From Concept to Approval (Part 2)

Lina Kontos spoke in the Master Class: Medical Device Clinical Research: The Path From Concept to Approval (Part 2) session at the Magi's Clinical Research Conference - 2018 West on Sunday, ...

The European regulatory framework and recent developments in telehealth

On 18 October 2018 we hosted a complimentary webinar discussing the recent regulatory changes of telehealth services, potential future developments, and some of the key legal issues to...

Loading data